Skip to main content
PLOS Pathogens logoLink to PLOS Pathogens
. 2022 May 23;18(5):e1010251. doi: 10.1371/journal.ppat.1010251

Live imaging of Yersinia translocon formation and immune recognition in host cells

Maren Rudolph 1,#, Alexander Carsten 1,#, Susanne Kulnik 1, Martin Aepfelbacher 1,*,#, Manuel Wolters 1,*,#
Editor: Jorn Coers2
PMCID: PMC9173619  PMID: 35604950

Abstract

Yersinia enterocolitica employs a type three secretion system (T3SS) to translocate immunosuppressive effector proteins into host cells. To this end, the T3SS assembles a translocon/pore complex composed of the translocator proteins YopB and YopD in host cell membranes serving as an entry port for the effectors. The translocon is formed in a Yersinia-containing pre-phagosomal compartment that is connected to the extracellular space. As the phagosome matures, the translocon and the membrane damage it causes are recognized by the cell-autonomous immune system. We infected cells in the presence of fluorophore-labeled ALFA-tag-binding nanobodies with a Y. enterocolitica strain expressing YopD labeled with an ALFA-tag. Thereby we could record the integration of YopD into translocons and its intracellular fate in living host cells. YopD was integrated into translocons around 2 min after uptake of the bacteria into a phosphatidylinositol-4,5-bisphosphate enriched pre-phagosomal compartment and remained there for 27 min on average. Damaging of the phagosomal membrane as visualized with recruitment of GFP-tagged galectin-3 occurred in the mean around 14 min after translocon formation. Shortly after recruitment of galectin-3, guanylate-binding protein 1 (GBP-1) was recruited to phagosomes, which was accompanied by a decrease in the signal intensity of translocons, suggesting their degradation or disassembly. In sum, we were able for the first time to film the spatiotemporal dynamics of Yersinia T3SS translocon formation and degradation and its sensing by components of the cell-autonomous immune system.

Author summary

Type 3 secretion systems (T3SS) are injection machines required for virulence of various bacteria. A translocon/pore complex is formed at the tip of the injection needle, which is required for translocation of effector proteins across the host cell membrane. To date, little information is available on the composition, structure, and regulation of the translocon. Here, we present a novel method that allows us to film the spatiotemporal dynamics of the Yersinia T3SS translocon by inserting a small peptide tag into the minor translocon protein YopD that can be bound with high affinity by a corresponding fluorophore-labeled nanobody during the infection process. By this the formation and disassembly of the translocon and its sensing by components of the cell-autonomous immune system could be recorded with high temporal resolution. The described approach has the potential to provide insights into the T3SS of other bacterial species and is likely transferable also to other secretion systems.

Introduction

Type three secretion systems (T3SSs) are multi-component, syringe-like nanomachines that enable the translocation of bacterial effector proteins across the bacterial envelope into eukaryotic host cells. Numerous human pathogenic bacteria such as Yersinia, Pseudomonas, Chlamydia, Shigella and Salmonella employ T3SS-mediated effector translocation to manipulate a variety of cellular processes, ultimately determining the nature of interaction with their hosts. T3SS effector proteins are diverse in structure and biochemical activities and vary considerably between species. In contrast, the T3SS machinery—also known as the injectisome—is highly conserved across different bacterial species and has been the subject of intensive structural and functional investigation [114].

Injectisomes can be separated into defined substructures such as the sorting platform, the export apparatus, the needle complex, the tip complex and the translocon (Fig 1A). The needle complex is a multi-ring cylindrical structure embedded in the bacterial envelope connected with a 30–70 nm long needle filament, forming a narrow channel, through which the translocator and effector proteins pass in an unfolded state [6,13]. The needle at its distal end transitions into the tip complex, which consists of several copies of a hydrophilic translocator protein (5 copies of LcrV in Yersinia) [9]. The tip complex is involved in host cell sensing and regulates the assembly of the translocon/pore complex [15].

Fig 1. Insertion of the ALFA-tag into YopD does not interfere with protein function and allows for nanobody-based staining of translocons.

Fig 1

(A) Schematic representation of the T3SS in Yersinia enterocolitica with ALFA-tagged YopD. The T3SS connecting the bacterial and host cell membranes. The enlargement shows the translocon with ALFA-tagged YopD labeled with a fluorescently tagged nanobody (NbALFA). IM: inner bacterial membrane. PG: bacterial peptidoglycan layer. OM: outer bacterial membrane. HCM: host cell membrane. Adapted from [4,11]. (B) Model of YopD-ALFA and YopB inserted into the host cell membrane. The scheme is adapted from [23] and based on data on interactions of Pseudomonas aeruginosa PopD and PopB. The red box indicates the inserted ALFA-tag between amino acids 194 and 195 on the extracellular part of YopD. (C) Released proteins of WA-314 and WA-314 YopD-ALFA. Secreted proteins were precipitated from the culture supernatant and analyzed by Coomassie stained SDS gel (upper panel) and Western blot (lower panel) for their YopD content using specific antibodies. Black asterisks indicate the position of the YopD bands in the SDS gel. (D) Staining of YopD-ALFA in translocons. Rac1Q61L expressing HeLa cells were infected with WA-314 YopD-ALFA at an MOI of 10 for 1 h, fixed and host cell membranes were permeabilized with digitonin. Co-staining of translocon components was conducted with anti-YopB (shown in green) and anti-YopD (shown in red) antibodies and NbALFA-635 (shown in magenta). Scale bar: 2 μm. (E) Comparison of effector protein translocation by β-lactamase assay. HeLa cells pretreated with a cell permeant FRET dye (CCF4/AM) were infected for 1 h with WA-314, WA-314 pYopE-bla and WA-314 YopD-ALFA pYopE-bla at an MOI of 100 and imaged by confocal microscopy. Excitation of coumarin results in FRET to fluorescein in the uncleaved CCF4 emitting a green fluorescent signal. Cleavage of the cephalosporin core of CCF4 by the beta-lactamase tagged to a truncated YopE translocated into the host cell disrupts FRET and results in a blue fluorescent signal induced by the excitation of coumarin. Cells with incomplete CCF4 cleavage appear cyan. Scale bar: 200 μm. The percentage of green, cyan and blue cells was determined in one experiment from 354, 329 and 305 cells for WA-314, WA-314 pMK-bla and WA-314-YopD-ALFA pMK-bla, respectively. (F) Cytotoxicity assay. HeLa cells were infected for 1 h with WA-314, WA-314 YopD-ALFA and WA-314ΔYopD at an MOI of 100 and imaged by phase contrast microscopy. Depicted are phase contrast images of a representative experiment. Scale bar: 20 μm.

The translocon of all investigated T3SSs consists of two hydrophobic translocator proteins, a major (YopB in Yersinia) and a minor translocator (YopD in Yersinia) harboring one and two transmembrane domains, respectively [16,17]. The two translocators are thought to form a heteromultimeric ring structure with an inner opening of approximately 2–4 nm in the host cell membrane [1820]. Despite the central role of the translocon for effector translocation, many aspects of its regulation, assembly and composition have remained elusive. The hydrophobic nature of the translocators and the fact that the assembled translocon can only be studied when inserted into host cell membranes, up to now hindered its investigation due to a lack of suitable experimental approaches.

In a recent cryo-electron tomography study the host cell membrane embedded translocon of Salmonella enterica minicells was found to have a total diameter of 13.5 nm [11]. In our previous work translocons of Yersinia enterocolitica were imaged by super resolution immunofluorescence techniques (STED, SIM) using antibodies against the translocator proteins YopB and YopD. Thereby, the host cellular context that promotes translocon formation could be investigated, revealing that the translocons are formed upon uptake of the bacteria into a phosphatidylinositol-4,5-bisphosphate (PIP2)—enriched pre-phagosomal compartment/prevacuole, which is still connected to the extracellular space [21].

While these approaches provided a considerable degree of spatial resolution, none of them was suitable for time resolved imaging of translocons. Live imaging of bacterium-host cell interactions using fluorescence microscopy has become a key technology for understanding bacterial infection biology [22]. However, live imaging of translocon formation and processing in host cells has not yet been accomplished. This is likely due to the elaborate und highly coordinated export of the hydrophobic translocator proteins through the T3SS needle and their interaction with the tip complex before they assemble a heteromultimeric translocon in the host cell membrane [16,23]. Thus, finding a label for translocon proteins that is e.g., suited for live cell imaging and super resolution and at the same time does not disturb translocon assembly has proven to be difficult. Fusion proteins of T3SS substrates with fluorescent proteins like GFP were shown to be resistant to T3SS-mediated unfolding and block the secretion path [12]. Several other tags (e.g. self-labeling enzymes Halo, CLIP, SNAP, split-GFP, 4Cys-tag/ FlAsH, iLOV) are secreted more effectively and have been used with varying degree of success for live imaging of translocated effectors [2428].

We here report the first live cell imaging data of Yersinia translocon formation, immune sensing and processing by employing a Yersinia strain carrying a novel 13 amino acid peptide tag called ALFA-tag in the minor hydrophobic translocator YopD [29]. These data provide novel insights on the spatiotemporal dynamics and immune recognition of bacterial T3SS translocons.

Results

Characterization of Y. enterocolitica strain WA-314 YopD-ALFA

During infection with pathogenic yersiniae, a translocon/heteromultimeric pore complex composed of the translocator proteins YopB and YopD is integrated into host cell membranes, serving as an entry gate for the effector proteins (Fig 1A). In search of a method to visualize translocons in living cells using fluorescence microscopy, we inserted the ALFA-tag sequence (plus linker sequences) into the endogenous copy of yopD in the wild type strain WA-314 by CRISPR-Cas assisted recombineering, resulting in strain WA-314 YopD-ALFA (see Materials and Methods). The resulting YopD protein harbors the ALFA-tag between amino acids 194 and 195. The ALFA-tag insertion site is supposedly located in the extracellular part of YopD after it has integrated into the host cell membrane (Fig 1B) [23]. The 13 amino acid long ALFA-tag can be bound with high affinity by specific nanobodies (NbALFA) [29].

We first investigated whether WA-314 YopD-ALFA retains wild type functionalities by comparing its secretion-, translocon forming- and translocation capabilities as well as cytotoxic effect with the parental strain WA-314 (Fig 1C–1F). To analyze effector secretion, the low calcium response was exploited, which triggers secretion of translocator- and effector proteins (Yersinia outer proteins; Yops) into the supernatant, when the bacteria are placed in calcium depleted medium at 37°C [2123]. SDS-PAGE and Western blot showed similar levels of total secreted proteins and secreted YopD-ALFA in WA-314 YopD-ALFA when compared to WA-314 (YopD-ALFA levels were compared to YopD levels), suggesting that protein secretion is unaffected in WA-314 YopD-ALFA (Fig 1C). Staining of WA-314 YopD-ALFA infected HeLa cells with fluorophore-labeled NbALFA revealed distinct fluorescence patches that were also detected by anti-YopD and anti-YopB antibodies (Fig 1D). Such patches have recently been shown to represent clusters of translocons [21]. Further, the ability of WA-314 YopD-ALFA to translocate effector proteins into host cells was examined using a well-established β-lactamase reporter system. This assay relies on cleavage of a cell permeant FRET dye (CCF4/AM) by a translocated YopE β-lactamase fusion protein. CCF4/AM-loaded HeLa cells were infected with WA-314 and WA-314 YopD-ALFA, both carrying pMK-bla encoding for YopE-β-lactamase. Both strains translocated similar amounts of a YopE β-lactamase fusion protein into host cells (Fig 1E) [3032]. Infection of HeLa cells with Yersinia leads to rounding of the cells and this phenomenon is referred to as cytotoxicity. Cytotoxicity is mainly mediated by the action of translocated effectors YopE and YopH and is thus an indicator of a functioning T3SS machinery and translocon. Rounding of HeLa cells was induced to a similar extent by infection with WA314 and WA-314 YopD-ALFA but not with WA314ΔYopD, indicating that translocon-dependent effector translocation into host cells is unaffected in WA-314 YopD-ALFA (Fig 1F). To determine whether binding of NbALFA to translocon-associated YopD-ALFA impairs translocon function, Hela cells were infected with WA-314 YopD-ALFA in the presence of NbALFA. NbALFA had no effect on translocation of the effector YopH, as determined by Western blotting of YopH extracted by digitonin lysis from HeLa cells, or on cytotoxicity (S1 Fig). We conclude that insertion of the ALFA tag into YopD and binding of NbALFA do not affect translocon function.

Fluorescence staining of YopD-ALFA in pre-phagosomes, phagosomes and Yersinia cells

In previous work we showed that translocon formation by Y. enterocolitica occurs in a specific pre-phagosomal host cell compartment, previously referred to as prevacuole [21,33]. The Yersinia-containing pre-phagosome is derived from the plasma membrane, enriched with PIP2 and characterized by a narrow connection to the extracellular space, which cannot be passed by large extracellular molecules such as antibodies (MW approx. 150 kDa), but by small molecules like streptavidin (MW 53 kDa) [21,33]. We therefore assumed that it should be feasible to stain YopD-ALFA in newly formed translocons by adding fluorophore-labeled NbALFA (MW 15 kDa) to fixed but unpermeabilized WA-314 YopD-ALFA infected cells. To test this notion and further investigate the localization of YopD-ALFA in the course of cell infection, we sequentially stained WA-314 YopD-ALFA infected HeLa cells without permeabilization (NbALFA-635), after permeabilization of the HeLa cell membranes with digitonin (NbALFA-580) and after additional permeabilization of the bacterial membranes with 0.1% Triton X-100 (NbALFA-488) (Fig 2A). In unpermeabilized HeLa cells, patchy fluorescence signals associated with bacteria could be detected (Fig 2A, left), confirming that translocon-associated YopD-ALFA can be accessed by extracellularly added NbALFA. In digitonin-permeabilized HeLa cells, additional translocon signals could be found that were not seen in unpermeabilized cells, indicating that these translocons resided in closed phagosomes (Fig 2A, middle). After additional permeabilization of the bacterial membranes with Triton X-100, the intrabacterial pool of YopD-ALFA could be visualized in all bacteria, independent of whether they displayed translocons (Fig 2A, right). The diffuse distribution of intrabacterial YopD-ALFA is in clear contrast to the patchy pattern of translocon-associated YopD-ALFA. To better resolve translocon associated from intrabacterial YopD-ALFA, we employed super resolution 2D and 3D STED microscopy (Fig 2B). While the intrabacterial distribution of YopD-ALFA remained diffuse also at this level of resolution, the extrabacterial YopD-ALFA produced distinct signals with a lateral extent of about 40 nm, which previously were identified as single translocons [21]. Overall, differential YopD-ALFA staining allows to visualize Yersinia translocons located in pre-phagosomes and phagosomes, as well as the intrabacterial YopD pool.

Fig 2. Differential permeabilization for selective staining of YopD-ALFA in different cellular compartments.

Fig 2

(A) Selective nanobody staining of YopD-ALFA in different cellular compartments. The schematic (top) shows different levels of host- and bacterial cell permeabilization and according accessibility of different pools of YopD-ALFA for NbALFA staining. Rac1Q61L expressing HeLa cells were infected with WA-314 YopD-ALFA at an MOI of 10 for 1 h, fixed and stained with NbALFA-635 without prior permeabilization to specifically target translocon associated YopD-ALFA in the pre-phagosomal compartment (left, shown in red). Host cell membranes were permeabilized with digitonin and translocons located in closed phagosomes were stained with NbALFA-580 (middle, shown in magenta). Note that pre-phagosomal YopD-ALFA was already saturated with NbALFA-635 (red) during the first staining step. Finally, also the bacterial membranes were permeabilized with triton and the intrabacterial pool of YopD-ALFA was stained with NbALFA-488 (right, shown in green). Scale bar: 5 μm. (B) 2D and 3D-STED imaging of intrabacterial and translocon-associated YopD-ALFA. Rac1Q61L expressing HeLa cells were infected with WA-314 YopD-ALFA at an MOI of 10 for 1 h, fixed and stained with NbALFA-635 (shown in red) with prior permeabilization of host cell membranes using digitonin to target translocon associated YopD-ALFA. Bacterial membranes were permeabilized with triton and the intrabacterial pool of YopD-ALFA was stained with NbALFA-580 (shown in green). The images were acquired using super resolution STED microscopy. The boxed region in the left of the image is depicted as enlargements in separate channels at the side. Scale bars: 1 μm (2D-STED overview and 3D STED) and 200 nm (2D-STED enlargements).

Live imaging of Yersinia translocon formation during cell infection

Given the ability to stain translocons in fixed and unpermeabilized cells by external addition of fluorophore-labeled NbALFA, we hypothesized that this may also enable the recording of translocon formation in living cells. To test this possibility, live HeLa cells expressing GFP-LifeAct and myc-Rac1Q61L were infected with WA-314 YopD-ALFA in the presence of NbALFA-580 and imaged using spinning disc microscopy with one acquisition per minute. myc-Rac1Q61L was overexpressed in all Hela cell live imaging experiments because it strongly increases the percentage of bacteria forming translocons (S2 Fig) by stimulating uptake of the bacteria into the pre-phagosome [21]. GFP-LifeAct was expressed to visualize host cells and to enable the localization of the cell adhering bacteria. With this approach, appearance and disappearance of fluorescence signals corresponding to translocon-associated YopD-ALFA could be recorded over time (representative event in Fig 3A and S1 Movie). From their first visible appearance (at 5 min in Fig 3A), the number and intensity of YopD-ALFA fluorescence signals peaked after about 20 min and decreased thereafter. The mean overall lifespan of YopD-ALFA fluorescence signals, defined as their first visible appearance until their complete vanishing, was determined to be 26.6 +/- 13 min (mean +/- S.D., Fig 3B). The disappearance of the fluorescence signals was most certainly not due to photo bleaching because no decay of fluorescence was observed in recordings with considerably higher imaging frequency (e.g. acquisition rate: 3 per min in Fig 3C vs. 1 per min in Fig 3A). To further evaluate potential photobleaching, HeLa cells were infected with WA-314 YopD-ALFA and fixed with paraformaldehyde. Fixed YopD-ALFA was stained with NbALFA-580 and subjected to live imaging employing the same conditions as for NbALFA-580-stained native YopD-ALFA. The fixed YopD-ALFA fluorescence signal decreased by 18% within 105 min, as compared to a 74% decrease of the signal in a representative live imaging experiment during 40 min (S3 Fig). This indicates that only minor photobleaching occurs during the live imaging time period und that a decrease of the fluorescence signal most likely is caused by degradation or dissolution of YopD-ALFA. Taken together, for the first time we filmed assembly and disassembly or degradation of T3SS translocons in living host cells, thus providing new insights into the spatiotemporal dynamics of this central T3SS activity.

Fig 3. Nanobody-based live imaging of translocons: Formation and lifespan of the translocon during cell infection.

Fig 3

(A) Live imaging of translocons during HeLa cell infection. HeLa cells expressing myc-Rac1Q61L and GFP-LifeAct were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in the cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every minute. Stacks for each time point were combined to one image using maximum intensity projection and one image every 5 min is shown. The left panel shows the overview image at 0 min. The boxed region in the overview image shows the area of the video depicted in still frames to the right. Dashed white lines indicate the outline of the bacteria. Scale bars: 10 μm (overview) and 2 μm (still frames). (B) Lifespan of the translocon. The lifespan of the translocons was determined using movies that recorded the YopD-signal of individual bacteria from their formation to disappearance. Experimental conditions are as in (A). n = 25 bacteria (7 independent experiments, 13 host cells) (C) Engulfment in PIP2-positive membranes precedes translocon formation in HeLa cells. HeLa cells expressing myc-Rac1Q61L and PLCδ1-PH-GFP were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every 20 s. Stacks for each time point were combined to one image using maximum intensity projection and one image every 20 s is shown. The left panel shows the overview image at 0 min. The boxed region in the overview image shows the area of the video depicted in still frames to the right. White arrows indicate the appearance of PLCδ1-PH-GFP and the first translocon signal. Scale bar: 10 μm (overview) and 2 μm (still frames). (D) Fluorescence intensities of PIP2 marker PLCδ1-PH-GFP and YopD-ALFA signals. The relative fluorescence intensities of PLCδ1-PH-GFP and NbALFA-580 signals at the bacteria in (C) were plotted to illustrate the temporal relationship of signal appearances. (E) Temporal relationship of engulfment in PIP2-positive membranes and appearance of YopD-ALFA signal. The time intervals between first occurrence of the PLCδ1-PH-GFP and first YopD-ALFA signals were measured based on live imaging experiments performed as in (C). Each dot represents one measurement. n = 43 bacteria (3 independent experiments, 13 movies). (F) Engulfment in PIP2-positive membranes precedes translocon formation in primary human macrophages. Primary human macrophages expressing PLCδ1-PH-GFP were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every minute. Stacks for each time point were combined to one image using maximum intensity projection and one image every 5 min is shown. The left panel shows the overview image at 0 min. The boxed region in the overview image shows the area of the video depicted in still frames to the right. White arrows indicate the appearance of PLCδ1-PH-GFP and the first translocon signal. Scale bars: 10 μm (overview) and 2 μm (still frames).

Spatiotemporal dynamics and sequence of uptake of Yersinia into the pre-phagosome followed by translocon formation

The ability to film translocons allowed us to study their spatiotemporal correlation with uptake of the bacteria into the pre-phagosome [21,33]. For this, we infected HeLa cells expressing the PIP2 sensor PLCδ1-PH-GFP with WA-314 YopD-ALFA in the presence of NbALFA-580 and performed live cell imaging (one z-stack every 20 s). Still frames of a representative event are depicted in Fig 3C, showing a bacterium being completely enclosed with PIP2 positive host membranes. Recruitment of PLCδ1-PH-GFP started at one pole of the bacterial cell und then continued until the whole cell was encompassed (Fig 3C). In the representative example, the time to complete encompassment of the bacterial cell was around 100 s (start and completion of recruitment at 20 s and 120 s, respectively; Fig 3C). In this example the first YopD-ALFA signal (at 80 s; Fig 3C) was observed about 60 s after the first PLCδ1-PH-GFP signal and occurred at the pole of the bacterium that was engulfed first by PLCδ1-PH-GFP (Fig 3C and 3D). Thereafter, the number and intensity of the YopD-ALFA translocon signals further increased until the 240 s time point (Fig 3C and 3D; S2 Movie). The median time lag between the first visible PLCδ1-PH-GFP and YopD-ALFA signals was determined to be 2.0 +/- 4.6 min (median +/- S.D., Fig 3E). Importantly, in all cases examined, the YopD-ALFA translocon signals occurred after or at the earliest simultaneously with the accumulation of PLCδ1-PH-GFP around the bacteria (Fig 3E). To test the spatiotemporal coordination of PIP2 accumulation and translocon formation in physiological target cells of pathogenic yersiniae, we employed primary human macrophages [34]. Live macrophages expressing PLCδ1-PH-GFP were infected with WA-314 YopD-ALFA in the presence of NbALFA-580 and investigated with live cell imaging. A representative movie shows that also in the macrophages the bacteria were enclosed with PLCδ1-PH-GFP positive membrane (at 5 min in Fig 3F; S3 Movie) before the YopD-ALFA translocon signals appeared (at 15 min in Fig 3F; S3 Movie). In summary, these data demonstrate a close spatiotemporal sequence of bacterial uptake into the pre-phagosome followed by T3SS translocon formation. This infers, but does not prove, that pre-phagosomal membrane composition or another host factor in this compartment triggers translocon formation.

Spatiotemporal dynamics of galectin-3 and GBP-1 recruitment to Yersinia containing phagosomes harboring translocons

It has previously been shown that the T3SS of Yersinia can damage the phagosome membranes surrounding these bacteria in cells [35,36]. Yet, the dynamics and spatiotemporal relationship between membrane damage and formation of translocons/pores, that are thought to induce the membrane disruption, have not been elucidated. GFP-galectin-3 has been used as a sensor for membrane damage because of its ability to attach to β-galactose-containing glycoconjugates present in the luminal leaflet of phagosomal membranes (Fig 4A) [37]. When expressed in the cytosol of host cells, GFP-galectin-3 accumulates at phagosomal membranes when these have been ruptured e.g., by T3SS translocons (Fig 4A). To first confirm that membranes are disrupted by the Yersinia T3SS, we infected HeLa cells expressing GFP-galectin-3 and myc-Rac1Q61L with different Yersinia strains (Table 1). We observed recruitment of GFP-galectin-3 by approximately 13% of both, cell-associated wild type WA-314 YopD-ALFA and effector-deficient WA-C pTTSS, but not by T3SS-deficient WA-C bacteria (Fig 4B). This confirms that phagosome disruption is caused by the Yersinia T3SS without the involvement of effectors.

Fig 4. Nanobody-based live imaging of translocons: Galectin-3 and GBP-1 recruitment upon translocon induced membrane damage.

Fig 4

(A) Schematic representation of galectin-3 recruitment following membrane damage during infection. Galectin-3 (shown in green) is found in the cytosol of the host cell. Translocon formation appears to induce membrane damage allowing access of galectin-3 to glycans in the lumen of vacuoles. (B) Vacuolar membrane damage by the T3SS. HeLa cells expressing myc-Rac1Q61L and GFP-galectin-3 were infected with WA-C, WA-C pTTSS and WA-314 YopD-ALFA at an MOI of 100 for 1 h, fixed and permeabilized using digitonin. Cells were stained with anti-YopD antibody, Alexa633 phalloidin and DAPI. The percentage of galectin-3 positive bacteria per cell was quantified for WA-C, WA-C pTTSS and WA-314 YopD-ALFA (n = 1680, 9 host cells; n = 508 bacteria, 7 host cells; n = 1065 bacteria, 10 host cells). Only cells harboring translocon forming bacteria were analyzed for WA-C pTTSS and WA-314 YopD-ALFA infections. (C) Fraction of galectin recruitments without and with prior YopD-ALFA signal. HeLa cells expressing myc-Rac1Q61L and GFP-galectin-3 were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every minute. Galectin-3 recruitment events were quantified with respect to whether YopD-ALFA signal is present before recruitment. n = 330 uptake events (6 independent experiments, 38 movies). (D) Temporal relationship of YopD-ALFA signal appearance and galectin-3 recruitment. HeLa cells expressing myc-Rac1Q61L and GFP-galectin-3 were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every minute. The time intervals between first occurrence of the translocon signal and first GFP-galectin-3 signals were measured. Each dot represents one measurement. n = 36 bacteria (4 independent experiments; 9 movies). (E) Galectin-3 recruitment to phagosomes containing translocon forming bacteria. Live imaging experiments were performed as in (C). The z-stacks for each time point were combined to one image using maximum intensity projection and one image every 5 min is representatively shown. Scale bar: 2 μm. The relative fluorescence intensities at the bacteria were plotted to illustrate the temporal relationship of NbALFA-580 and GFP-galectin-3 signals. (F) Loss of YopD-ALFA signal after GFP-galectin-3 recruitment. Live imaging experiments were performed as in (C). The relative fluorescence intensities of the translocon signal were measured in the last frame before and in the frames 5 min and 10 min after recruitment of GFP-galectin-3. n = 4 measurements (1 experiment, 3 host cells). (G) GBP-1 recruitment to galectin-3 positive bacteria. HeLa cells expressing myc-Rac1Q61L, mScarlet-galectin-3 (shown in green) and GFP-GBP-1 (shown in red) were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 (shown in magenta) diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every 5 minutes. The z-stacks for each time point were combined to one image using maximum intensity projection and images are shown starting 20 min after uptake of the bacteria. Scale bar: 5 μm. (H) GBP-1 positive bacteria lack LPS antibody staining. HeLa cells expressing myc-Rac1Q61L and GFP-GBP-1 (shown in green) were infected with WA-314 YopD-ALFA at an MOI of 30, fixed and permeabilized using digitonin. Cells were stained with anti-LPS antibody (shown in magenta). The boxed regions (I, II) in the overview image are depicted as enlargements in separate channels to the right. Dashed white lines indicate the outline of the nucleus in the overview image and the bacteria in the enlargements. Scale bar: 10 μm (overview) and 2 μm (enlargement).

Table 1. Yersinia enterocolitica strains.

Strain Relevant characteristic Source/References
WA-314 wild type strain carrying virulence plasmid pYV; serogroup O8; kanamycin resistance cassette in non-coding region of pYV-O8 [51,53]
WA-C pYV-cured derivative of WA-314 [53]
WA-C pTTSS WA-C harboring pTTSS encoding the TTSS secretion/translocation apparatus of WA-314 but no Yop effector genes; SptR [54]
WA-314ΔYopD WA-C harboring pYVΔyopD; KanR [21]
WA-314 YopD-ALFA WA-314 with ALFA-tag inserted in YopD; KanR this study
WA-314 pMK-bla WA-314 harboring pMK-bla containing YopE53-β-lactamase fusion; KanR, CMR [31]
WA-314 YopD-ALFA pMK-bla WA-314 YopD-ALFA harboring pYopE-bla; KanR, CMR this study

To test the spatiotemporal relation of translocon formation and membrane damage, we infected HeLa cells expressing GFP-galectin-3 with WA-314 YopD-ALFA in the presence of NbALFA-580 and performed live cell imaging. This revealed that GFP-galectin-3 recruitment was preceded by detectable YopD-ALFA signals in 92.6% +/- 5.6% (mean +/- S.D.) of all GFP-galectin-3 recruitment events (Fig 4C). The mean time interval between translocon formation and GFP-galectin-3 recruitment was determined to be 13.9 +/-6.3 min (mean +/- S.D., Fig 4D). We also noticed that GFP-galectin-3 was recruited relatively abruptly to the entire phagosomal membrane and that its recruitment was accompanied by a decrease in the YopD-ALFA translocon signal (n = 4; Fig 4E and 4F and S4 Movie). After we excluded that photobleaching causes relevant reduction in YopD-ALFA/NbALFA fluorescence signals in our experiments (S3 Fig), we wanted to obtain alternative evidence for YopD degradation after GFP-galectin-3 recruitment. For this, we compared and quantified NbALFA- and antibody-mediated fluorescence stainings of YopD-ALFA and YopD, respectively, in fixed cells. The results complement the live imaging data and very clearly show that both, NbALFA- and antibody-mediated fluorescence signals of translocons diminish or disappear at bacteria surrounded by GFP-galectin-3 (S4 Fig). These results suggest that the translocon protein YopD is degraded or disassembled in association with galectin-3 recruitment but do not formally prove that galectin-3 is functionally involved in YopD disappearance.

Recently it was shown that galectin-3 promotes recruitment of the guanylate-binding proteins (GBPs) GBP-1 and GBP-2 to Yersinia-containing compartments [35]. GBPs belong to the family of interferon-inducible GTPases and facilitate cell-intrinsic immunity by targeting host defense proteins to pathogen containing compartments [38]. Further, GBP-1 was recently shown to directly bind to LPS of Gram-negative bacteria and function as an LPS-clustering surfactant that disrupts the physicochemical properties of the LPS layer [3941]. To investigate the spatiotemporal coordination of galectin-3 and GBP-1 recruitment to bacteria that formed translocons, HeLa cells co-expressing galectin-3-mScarlet and GFP-GBP-1 were infected with WA-314 YopD-ALFA in the presence of NbALFA-580 and subjected to live cell imaging (Fig 4G; S5 Movie). GFP-GBP-1 was recruited specifically to bacteria that previously had formed translocons and recruited GFP-galectin-3 (100% of observed GFP-GBP-1 recruitment events, n = 45). GFP-GBP-1 recruitment (to bacteria that had formed translocons) was regularly observed shortly after or concomitant with GFP-galectin-3 recruitment (Fig 4G; S5 Movie). Staining with an anti-O8 LPS antibody failed to stain GBP-1 coated bacteria suggesting that GBP-1 interacts with the Yersinia LPS and hinders detection by the anti-LPS antibody (Fig 4H). These data suggest that Yersinia translocons cause disruption of phagosomal membranes which leads to sequential galectin-3 and GBP-1 recruitment and, likely through the recruitment of additional factors, to translocon degradation or disassembly.

Discussion

Here we used live cell imaging to characterize the spatiotemporal sequence of molecular events associated with Yersinia translocon assembly and disassembly in host cells. To this end, we constructed a Yersinia strain expressing an ALFA-tag labeled YopD that retained its functionality and could be visualized in fixed and living cells by binding to a fluorescently labeled nanobody (NbALFA). Live cell imaging was also facilitated by the fact that Yersinia translocon formation occurs in a pre-phagosomal host cell compartment where YopD-ALFA is accessible by externally added NbALFA. Thus the incorporation of YopD-ALFA into translocons, as measure for translocon formation, could be recorded and temporally and spatially correlated with the accumulation of the following biosensors i) PLCδ1-PH-GFP, which senses PIP2 at the pre-phagosome; ii) GFP-galectin-3, which senses phagosomal membrane disruption; and iii) GFP-GBP1, which senses activation of the cell autonomous immune system at the phagosome.

Translocon formation was always initiated seconds to a few minutes after engulfment of the bacteria in PIP2 positive membranes of the pre-phagosome, suggesting that a specific host cell factor in the pre-phagosomes may trigger the secretion of translocon proteins by the T3SS and/or is required for their membrane integration. PIP2 rich pre-phagosomes may also recruit host cell receptors like FPR1 and CCR5, which have been reported to promote Y. pestis and Y. pseudotuberculosis translocon formation [15,42].

Disruption of the phagosomal membrane by Yersinia required a functional T3SS, was associated with only a small fraction of cell-associated bacteria on which we previously detected translocons in >90%, and occurred with a delay of approximately 14 min after translocon formation. This indicates that membrane integration of the translocons per se is not sufficient for membrane disruption and subsequent entry of galectin-3. It remains to be elucidated how translocons compromise the phagosome membrane, e.g., whether they act in terms of unregulated translocon activity if they are separated from the T3SS during phagosome maturation or whether membrane disrupting host immune factors that recognize the translocon might be involved.

In a recent study galectin-3 was found to recruit the guanylate binding proteins (GBPs) GBP-1 and GBP-2 to Yersinia containing vacuoles dependent on a functional T3SS [35]. GBPs belong to the large group of interferon induced antimicrobial host cell factors known to be recruited to pathogen-containing vacuoles (PVs). They escort antimicrobial factors to the PVs and thereby contribute to the cell-autonomous immunity [38,43]. Of note, the galectin-3 signal in our study usually covered the whole circumference of the bacteria indicating that the membrane is not substantially ruptured or detached from the bacteria as described for Shigella [37,44]. GFP-galectin-3 and GBP1-GFP were sequentially recruited to bacteria-containing phagosomes that previously had formed translocons and were associated with a reduction of the YopD-ALFA and LPS signals. The exact mechanisms responsible for the obvious dissolution of the translocon and the bacterial cell membranes are not known. Future experiments involving galectin-3 or GBP1 knockout cell lines are needed to investigate whether these factors are involved in pathways leading to translocon degradation.

In summary, we here describe a new method for visualizing and filming the assembly and disassembly of Yersinia translocons by fluorescence microscopy in living cells. In this way, key aspects of the dynamics of translocon formation, its effects on membrane integrity, and recognition by host cell defense mechanisms could be recorded with high spatiotemporal resolution. The described approach might also be valuable for imaging of translocator proteins in other bacterial species. For this it will be critical to insert the tag into positions in the different translocators so that no interference with translocon function occurs.

More highly resolved molecular details of T3SS translocon formation, the effects of translocon pores on host membranes and their recognition by host immune factors may become available through the development and application of super resolution live imaging technologies like live cell STED and MINFLUX microscopy [45].

Materials and methods

Ethics statement

Approval for the analysis of anonymized blood donations (WF-015/12) was obtained by the Ethical Committee of the Ärztekammer Hamburg (Germany).

Materials

All standard laboratory chemicals and supplies were purchased from Roth (Karlsruhe, Germany), Sigma-Aldrich (Steinheim, Germany) or Merck (Hohenbrunn, Germany) unless indicated otherwise.

Plasmids

The following plasmids were described previously: PLCδ1-PH-GFP [46] was provided by Tamás Balla (National Institutes of Health, Bethesda, MD). The myc-Rac1Q61L plasmid [47] was kindly provided by Dr. Pontus Aspenström (Uppsala University, Uppsala, Sweden) and the GFP-GBP-1 plasmid [41] by P. Broz (University of Lausanne, Epalinges, Switzerland). pEGFP-galectin-3 [48] was a gift from Tamotsu Yoshimori (Addgene plasmid # 73080) and the mScarlet-galectin 3 was generated by using the pEGFP-galectin-3 plasmid and replacing eGFP by mScarlet at the NheI/BglII sites. pCMV-NbALFA-mScarlet-I (NanoTag Biotechnologies, Germany) was used as PCR amplification template (mScarlet fwd NheI: AGATCCGCTAGCGATGGTGAGCAAGGGCGAG; mScarlet rev BglII: TGCCATAGATCTCTTGTACAGCTCGTCCAT). The plasmid pMK-bla [49] was kindly provided by Erwin Bohn (Institute of Medical Microbiology and Hygiene, University of Tuebingen, Tuebingen, Germany) and the Lifeact-eGFP construct [50] was a kind gift of Michael Sixt (Max Planck Institute for Biochemistry, Munich, Germany).

Antibodies and nanobodies

Polyclonal rabbit anti-YopB (aa 1–168) and anti-YopD (aa 150–287) as well as rat anti-YopB (aa 1–168) antibodies were produced as described previously [21]. Rabbit polyclonal anti-Y. enterocolitica O:8 was purchased from Sifin (Berlin, Germany). Secondary anti-IgG antibodies and their sources were: Alexa488 chicken goat anti-rat, Alexa568 goat anti-rabbit, Alexa647 goat anti-rabbit, (Molecular Probes, Karlsruhe, Germany), horseradish peroxidase linked donkey anti-rabbit (GE Healthcare, Chicago, USA). Fluorescently labeled primary camelid anti-ALFA nanobodies (NbALFA) and their source were: Alexa Fluor 488 FluoTag-X2 (NbALFA-488), Alexa Fluor 580 FluoTag-X2 (NbALFA-580), AbberiorStar635P FluoTag-X2 (NbALFA-635) (NanoTag Biotechnologies, Göttingen, Germany).

Source and generation of Yersinia mutants

The Yersinia strains used here are listed in Table 1. Y. enterocolitica wild type strain WA-314 was a gift of Jürgen Heesemann (Max von Pettenkofer Institute, Munich, Germany) and described previously [51]. WA-314 YopD-ALFA was generated using a CRISPR-Cas12a-assisted recombineering approach [52]. In brief, a double stranded Homology Directed Repair (HDR) fragment containing the ALFA-tag and linker sequence was generated via overlap extension PCR. For this a 500 bp homology arm (HomA) was amplified from the Y. enterocolitica pYV virulence plasmid with the reverse primer YopD-ALFA HomA rev including part of the ALFA-tag insert and linker and the corresponding forward primer YopD-ALFA HomA fwd. The other homology arm (HomB) was amplified using the forward primer YopD-ALFA HomB fwd including the remaining part of the ALFA-tag insert and linker and the corresponding reverse primer YopD-ALFA HomB rev. Both homology arms were used as templates in an overlap extension PCR using the outer primers (YopD-ALFA HomA fwd and YopD-ALFA HomB rev) to generate the final HDR fragment.

The crRNAs required for targeting Cas12a to the defined insertion site were designed based on the 20 bp protospacer following the 3’-end of a PAM (5’-TTN-3’). The respective oligonucleotides were designed with Eco31L overhangs at the 5’- and 3’-ends (YopD-crRNA fwd and YopD-crRNA rev), annealed and ligated into the Eco31L digested pAC-crRNA vector harboring also a sacB sucrose sensitivity gene. 700 ng of the HDR fragment and 350 ng of the pAC-crRNA were electroporated into an electrocompetent WA-314 strain carrying pKD46-Cas12a, which harbors the lambda Red recombinase under control of an arabinose inducible promotor, Cas12a (Cas12a/Cpf1 from Francisella novicida) and a temperature-sensitive replicon. After successful editing of the virulence plasmid, the pAC-crRNA and pKD46-Cas12a plasmids were cured from the bacteria. Correct insertion of the ALFA-tag was confirmed by PCR and sequencing. The editing resulted in the expression of a modified YopD carrying the ALFA-tag between amino acids 194 and 195 (GGSGGSGGPSRLEEELRRRLTEPGGGGS; linker, ALFA-tag, linker).

Oligonucleotides and sequences

The oligonucleotides and sequences used are listed in Table 2.

Table 2. Oligonucleotides and sequences.

YopD-ALFA HomA fwd TATTATCCTAACTTATTATTTTTAATTTAATAATAAAAGCCCTGGATTACCATTAGTTAA
YopD-ALFA HomA rev TTGGAAGAGGAACTGAGACGCCGCTTAACTGAACCAGGCGGAGGTGGATCTATCGGGAGAATATGGAAACCAGA
YopD-ALFA HomB fwd GCGGCGTCTCAGTTCCTCTTCCAAACGGCTCGGGCCACCAGACCCGCCCGAACCACCATCCTCTCTGCTTACCGCTTTAT
YopD-ALFA HomB rev AAAGCGGTGAGGTTAAAAAAA
YopD-crRNA fwd TAGATCATATTCTCCCGATATCCTC
YopD-crRNA rev AGACGAGGATATCGGGAGAATATGA
final insert sequence (linker, ALFA-tag, linker) GGTGGTTCGGGCGGGTCTGGTGGCCCG AGCCGTTTGGAAGAGGAACTGAGACGCCGCTTAACTGAA CCAGGCGGAGGTGGATCT

Cell culture and transfection

HeLa cells (ACC#57, DSMZ-German Collection of Microorganisms and Cell Cultures) were cultured at 37°C and 5% CO2 in DMEM (Invitrogen, GIBCO, Darmstadt, Germany) supplemented with 10% FCS (v/v). For infection with bacteria, HeLa cells were seeded in 6 well plates (3x105 cells per well) or on glass coverslips (6x104 cells per well; confocal: Precision coverslips, round, 12 mm diameter, No 1.5, with precision thickness, Hartenstein, Würzburg, Germany; STED: 12mm, No. 1.5H for high resolution, Marienfeld GmbH, Lauda-Königshafen, Germany). For live imaging 2.5 x 104 HeLa cells were seeded in ibidi μ-slide 8 wells (ibidi, Martinsried, Germany). HeLa cells were transfected with 0.25 μg plasmid for coverslips or 0.125 μg plasmid for 8 well slides using Turbofect (Thermo Fisher Scientific, Waltham, Massachusetts, USA) for 16 h according to the manufacturer’s protocol.

Human peripheral blood monocytes were isolated from heparinized blood as described previously [55]. Monocytes/Macrophages were cultured in RPMI1640 (Invitrogen) containing 20% heterologous human serum (v/v) for 7 days with medium changes every three days. Macrophages were transfected with the Neon Transfection System (Invitrogen) with 5 μg DNA per 106 cells (1000 V, 40 ms, 2 pulses) and infected 4 h after transfection.

Preparation of bacteria

Yersinia were grown in lysogeny broth (LB) supplemented with nalidixic acid, kanamycin, spectinomycin or chloramphenicol as required at 27°C overnight and then diluted 1:20 in fresh LB broth, followed by cultivation at 37°C for 1.5 h to induce expression of the T3SS. For cell infection, bacteria were centrifuged, resuspended in ice-cold PBS and added to target cells at a defined multiplicity of infection (MOI), as specified in the figure captions. Bacteria were then centrifuged at 200 x g for 1 min onto the target cells to synchronize the bacterial attachment. For in-vitro Yop secretion, EGTA (5 mM), MgCl2 (15 mM) and glucose (0.2%, w/v) was added to the growth medium for Ca2+ chelation after 1.5 h at 37°C, followed by another 3 h of incubation at 37°C, as described before [54]. The resulting samples were analyzed by SDS-PAGE, followed by either Coomassie staining or transfer to a PVDF membrane (Immobilon-P, Millipore), and analysis by Western blot using antisera against YopB and YopD.

Fluorescence labeling

Infected cells were washed twice with PBS and fixed with 4% PFA (v/v; Electron Microscopy Science, Hatfield, USA) in PBS for 5 min. Samples were treated with digitonin solution (90 μg/mL in PBS) to permeabilize cellular membranes and allow access of the nanobody to translocon-associated YopD-ALFA. For antibody stainings or staining of intrabacterial YopD-ALFA using the nanobody, samples were permeabilized with 0.1% Triton X-100 (v/v) in PBS for 15 min. After fixation and permeabilization coverslips were washed twice with PBS. Unspecific binding sites were blocked with 3% bovine serum albumin (BSA, w/v) in PBS for at least 30 min. Samples were then incubated with the indicated primary antibody (1:50) or fluorescently labeled FluoTag-X2 anti-ALFA nanobody (1:200) for 1 h (16 h for STED samples using the nanobody) and incubated with a 1:200 dilution of the suitable fluorophore-coupled secondary antibody or fluorophore-coupled phalloidin (1:200, Invitrogen) and 4’,6-diamidino-2-phenylindole (DAPI; 300 nM, Invitrogen) as indicated for 45 min. Nanobodies as well as primary and secondary antibodies were applied in PBS supplemented with 3% BSA. After each staining coverslips were washed three times with PBS. Coverslips for confocal microscopy were mounted in ProLong Diamond (Thermo Fisher Scientific) while STED samples were mounted in ProLong Gold (Thermo Fisher Scientific, Waltham, USA).

Confocal microscopy

Fixed samples were analyzed with a confocal laser scanning microscope (Leica TCS SP8) equipped with a 63x oil immersion objective (NA 1.4) and Leica LAS X SP8 software (Leica Microsystems, Wetzlar, Germany) was used for acquisition.

Live cell imaging

For live imaging the cells were seeded in 8 well slides and were placed in the prewarmed chamber supplied with 5% CO2 of the spinning disc microscope Visitron SD-TRIF (Nikon Eclipse TiE, Nikon, Japan) with a 63x oil immersion objective (NA 1.40) and the VisiView software (Visitron Systems, Germany). The nanobody was diluted 1:200 in 200 μl DMEM with 10% FCS and mixed with the WA-314 YopD-ALFA. The number of bacteria was chosen according to the intended MOI. The medium was removed from the cells and the 200 μl medium containing nanobody and bacteria was added. The imaging process was started immediately.

Super resolution imaging

STED nanoscopy and corresponding confocal microscopy were carried out in line sequential mode using an Abberior Instruments Expert Line STED microscope based on a Nikon Ti-E microscopy body and employed for excitation and detection of the fluorescence signal a 60x Plan APO 1.4 oil immersion objective. A pulsed 640 nm laser was used for excitation and a pulsed near-infrared laser (775 nm) was used for STED. The detected fluorescence signal was directed through a variable sized pinhole (1 Airy unit at 640 nm) and detected by avalanche photo diodes (APDs) with appropriate filter settings for Cy5 (615–755 nm). Images were recorded with a dwell time of 0.5 μs and the pixel size was set to be 10 nm for 2D-STED or the voxel size was set to 40x40x50 nm for 3D-STED. The acquisitions were carried out in time gating mode i.e. with a time gating delay of 750 ps and a width of 8 ns. 3D-STED images were acquired with 80% 3D-STED donut.

Image analysis

The z-stacks of images acquired of both fixed and live samples were combined to one image using maximum intensity projection. These images were used to determine the lifespan of a detectable translocon signal, the fluorescence intensity of PLCδ1-PH and YopD-ALFA signal in a region of interest around the bacterium for each time point as well as the time PLCδ1-PH is present before translocon formation. In addition, the percentage of galectin-3 positive bacteria in cells harboring translocon forming bacteria was quantified in fixed samples. Live imaging was used to determine the number of galectin-3 positive bacteria with and without prior YopD-ALFA signal as well as the time interval between translocon formation and galectin-3 recruitment. The fluorescence intensity of YopD-ALFA and GFP-galectin-3 signal was measured in a region of interest around the bacterium for each time point of a representative movie. In general, the fluorescence intensity measurements were normalized to the lowest intensity measured and the highest intensity value was set to 100%. Live imaging data were additionally analyzed for the presence of galectin-3 before GBP-1 recruitment to phagosomes.

Detection of Bla-activity by immunofluorescence microscopy

One day before infection 2.5 x 104 HeLa cells were seeded in ibidi μ-Slide 8 wells. The following day cells were infected with different bacterial strains as indicated and after 30 min the medium was replaced by 200 μl CCF4/AM loading solution (prepared according to the manufacturer’s instructions) diluted in DMEM supplemented with 10% FCS and 2.5 mM probenecid. The cells were placed in the prewarmed chamber supplied with 5% CO2 of the laser scanning microscope Leica TCS SP8 and imaging was performed using a 20x oil immersion objective (NA 0.75) and the Leica LAS X SP8 software (Leica Microsystems, Wetzlar, Germany).

Supporting information

S1 Fig. NbALFA does not inhibit WA-314 YopD-ALFA effector translocation or cytotoxicity.

(A) Digitonin assay. Hela cells were infected with WA-314 YopD-ALFA at an MOI of 100. NbALFA-580 was diluted in cell culture medium as indicated. Cells were lyzed with digitonin and resulting supernatants (containing membrane integrated and soluble Yops from host cells) and cell pellets (containing intact bacteria and digitonin insoluble cell components) were analyzed with Western blot for the indicated proteins. YopH serves as marker for effector translocation, myc indicates myc-Rac1QL61 expression, calnexin serves as host cell loading control and HSP60 serves as bacterial loading and lysis control. Data are representative of 2 independent experiments. (B) Cytotoxicity assay. HeLa cells were infected for 1 h with WA-314 YopD-ALFA at an MOI of 100 and imaged by phase contrast microscopy. NbALFA was diluted in cell culture medium as indicated. Depicted are phase contrast images of a representative experiment. Scale bar: 20 μm.

(TIF)

S2 Fig. Rac1Q61L expression enhances translocon formation by WA-314 YopD-ALFA in Hela cells.

Control or myc-Rac1Q61L transfected Hela cells were infected with WA-314 YopD-ALFA at an MOI of 50 for 50 min, fixed and stained with NbALFA-647 (shown in red) with prior permeabilization of host cell membranes using digitonin. Cells are visualized using phalloidin 488 (shown in green). Scale bar: 20 μm.

(TIF)

S3 Fig. Live imaging of fixed and stained YopD-ALFA.

Hela cells were infected at an MOI of 50 for 50 minutes, fixed, permeabilized with digitonin and incubated with NbALFA-580 and phalloidin 488. After addition of cell culture medium, cells were imaged with a spinning disk microscope recording z-stacks every minute for 105 min employing the same imaging conditions as for live cell imaging (e.g. for Fig 4E). The z-stacks for each time point were combined to one image using maximum intensity projection and one image every 15 min is representatively shown. The left panel shows the overview image at 0 min. The boxed region in the overview image shows the area of the video depicted in still frames to the right. Scale bars: 20 μm (overview) and 5 μm (still frames). The relative fluorescence intensity of the NbALFA-580 signals were plotted. For comparison, the live cell imaging data from Fig 4E were included in the graph.

(TIF)

S4 Fig. Low translocon associated YopD-ALFA/YopD fluorescence signals in GFP-galectin-3 positive compartments.

(A) NbALFA staining of translocon associated YopD-ALFA in fixed cells. HeLa cells expressing myc-Rac1Q61L and GFP-galectin-3 were infected with WA-314-YopD-ALFA at an MOI of 50 for 50 min. Cells were fixed, permeabilized with digitonin and stained with NbALFA-647. Scale bars: Overview 10 μm, zoom 2 μm. (B) Semiquantitative categorization of NbALFA signal intensities in galectin-3 positive and negative compartments. Experimental conditions as in A. Bacteria in galectin-3 negative and positive compartments were categorized according to the intensity of YopD-ALFA signals (+/-: no/weak intensity; ++: medium intensity; +++: strong intensity). Total number of bacteria evaluated: n = 400 (C) Immunostaining of translocon associated YopD in fixed cells. Experimental conditions as in A but infection with WA-314 and staining with purified polyclonal anti-YopD antibody. Scale bars: Overview 10 μm, zoom 2 μm.

(TIF)

S1 Movie. Live imaging of translocons during HeLa cell infection.

HeLa cells expressing myc-Rac1Q61L and GFP-LifeAct were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in the cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every minute. Stacks for each time point were combined to one image using maximum intensity projection. Scale bar: 2 μm.

(AVI)

S2 Movie. Engulfment in PIP2-positive membranes precedes translocon formation in HeLa cells.

HeLa cells expressing myc-Rac1Q61L and PLCδ1-PH-GFP were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every 20 s. Stacks for each time point were combined to one image using maximum intensity projection. Scale bar: 2 μm.

(AVI)

S3 Movie. Engulfment in PIP2-positive membranes precedes translocon formation in primary human macrophages.

Primary human macrophages expressing PLCδ1-PH-GFP were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every minute. Stacks for each time point were combined to one image using maximum intensity projection. Scale bar: 2 μm.

(AVI)

S4 Movie. Galectin-3 recruitment to vacuoles containing translocon forming bacteria.

HeLa cells expressing myc-Rac1Q61L and GFP-galectin-3 were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every minute. The z-stacks for each time point were combined to one image using maximum intensity projection. Scale bar: 2 μm.

(AVI)

S5 Movie. GBP-1 recruitment to galectin-3 positive bacteria.

HeLa cells expressing myc-Rac1Q61L, mScarlet-galectin-3 (shown in green) and GFP-GBP-1 (shown in red) were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 (shown in magenta) diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every 5 minutes. The z-stacks for each time point were combined to one image using maximum intensity projection. Scale bar: 5 μm.

(AVI)

Acknowledgments

We thank the UKE microscopy imaging facility (umif) for training and support. We thank Tomas Edgren for helpful discussion and knowing where to tag YopD.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This study was supported by the Joachim Herz Foundation (www.joachim-herz-stiftung.de) given to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Deng W, Marshall NC, Rowland JL, McCoy JM, Worrall LJ, Santos AS, et al. (2017) Assembly, structure, function and regulation of type III secretion systems. Nat Rev Microbiol 15: 323–337. doi: 10.1038/nrmicro.2017.20 [DOI] [PubMed] [Google Scholar]
  • 2.Lara-Tejero M, Galan JE (2019) The Injectisome, a Complex Nanomachine for Protein Injection into Mammalian Cells. EcoSal Plus 8. doi: 10.1128/ecosalplus.ESP-0039-2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Pinaud L, Sansonetti PJ, Phalipon A (2018) Host Cell Targeting by Enteropathogenic Bacteria T3SS Effectors. Trends Microbiol 26: 266–283. doi: 10.1016/j.tim.2018.01.010 [DOI] [PubMed] [Google Scholar]
  • 4.Berger C, Ravelli RBG, Lopez-Iglesias C, Kudryashev M, Diepold A, Peters PJ (2021) Structure of the Yersinia injectisome in intracellular host cell phagosomes revealed by cryo FIB electron tomography. J Struct Biol 213: 107701. doi: 10.1016/j.jsb.2021.107701 [DOI] [PubMed] [Google Scholar]
  • 5.Hu J, Worrall LJ, Hong C, Vuckovic M, Atkinson CE, Caveney N, et al. (2018) Cryo-EM analysis of the T3S injectisome reveals the structure of the needle and open secretin. Nat Commun 9: 3840. doi: 10.1038/s41467-018-06298-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kubori T, Matsushima Y, Nakamura D, Uralil J, Lara-Tejero M, Sukhan A, et al. (1998) Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 280: 602–605. doi: 10.1126/science.280.5363.602 [DOI] [PubMed] [Google Scholar]
  • 7.Lunelli M, Kamprad A, Burger J, Mielke T, Spahn CMT, Kolbe M (2020) Cryo-EM structure of the Shigella type III needle complex. PLoS Pathog 16: e1008263. doi: 10.1371/journal.ppat.1008263 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Marlovits TC, Kubori T, Sukhan A, Thomas DR, Galan JE, Unger VM (2004) Structural insights into the assembly of the type III secretion needle complex. Science 306: 1040–1042. doi: 10.1126/science.1102610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mueller CA, Broz P, Muller SA, Ringler P, Erne-Brand F, Sorg I, et al. (2005) The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310: 674–676. doi: 10.1126/science.1118476 [DOI] [PubMed] [Google Scholar]
  • 10.Nans A, Kudryashev M, Saibil HR, Hayward RD (2015) Structure of a bacterial type III secretion system in contact with a host membrane in situ. Nat Commun 6: 10114. doi: 10.1038/ncomms10114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Park D, Lara-Tejero M, Waxham MN, Li W, Hu B, Galan JE, et al. (2018) Visualization of the type III secretion mediated Salmonella-host cell interface using cryo-electron tomography. Elife 7. doi: 10.7554/eLife.39514 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Radics J, Konigsmaier L, Marlovits TC (2014) Structure of a pathogenic type 3 secretion system in action. Nat Struct Mol Biol 21: 82–87. doi: 10.1038/nsmb.2722 [DOI] [PubMed] [Google Scholar]
  • 13.Schraidt O, Marlovits TC (2011) Three-dimensional model of Salmonella’s needle complex at subnanometer resolution. Science 331: 1192–1195. doi: 10.1126/science.1199358 [DOI] [PubMed] [Google Scholar]
  • 14.Worrall LJ, Hong C, Vuckovic M, Deng W, Bergeron JRC, Majewski DD, et al. (2016) Near-atomic-resolution cryo-EM analysis of the Salmonella T3S injectisome basal body. Nature 540: 597–601. doi: 10.1038/nature20576 [DOI] [PubMed] [Google Scholar]
  • 15.Osei-Owusu P, Charlton TM, Kim HK, Missiakas D, Schneewind O (2019) FPR1 is the plague receptor on host immune cells. Nature 574: 57–62. doi: 10.1038/s41586-019-1570-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mattei PJ, Faudry E, Job V, Izore T, Attree I, Dessen A (2011) Membrane targeting and pore formation by the type III secretion system translocon. FEBS J 278: 414–426. doi: 10.1111/j.1742-4658.2010.07974.x [DOI] [PubMed] [Google Scholar]
  • 17.Mueller CA, Broz P, Cornelis GR (2008) The type III secretion system tip complex and translocon. Mol Microbiol 68: 1085–1095. doi: 10.1111/j.1365-2958.2008.06237.x [DOI] [PubMed] [Google Scholar]
  • 18.Neyt C, Cornelis GR (1999) Insertion of a Yop translocation pore into the macrophage plasma membrane by Yersinia enterocolitica: requirement for translocators YopB and YopD, but not LcrG. Mol Microbiol 33: 971–981. doi: 10.1046/j.1365-2958.1999.01537.x [DOI] [PubMed] [Google Scholar]
  • 19.Ide T, Laarmann S, Greune L, Schillers H, Oberleithner H, Schmidt MA (2001) Characterization of translocation pores inserted into plasma membranes by type III-secreted Esp proteins of enteropathogenic Escherichia coli. Cell Microbiol 3: 669–679. doi: 10.1046/j.1462-5822.2001.00146.x [DOI] [PubMed] [Google Scholar]
  • 20.Blocker A, Gounon P, Larquet E, Niebuhr K, Cabiaux V, Parsot C, et al. (1999) The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes. J Cell Biol 147: 683–693. doi: 10.1083/jcb.147.3.683 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Nauth T, Huschka F, Schweizer M, Bosse JB, Diepold A, Failla AV, et al. (2018) Visualization of translocons in Yersinia type III protein secretion machines during host cell infection. PLoS Pathog 14: e1007527. doi: 10.1371/journal.ppat.1007527 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yao Z, Carballido-Lopez R (2014) Fluorescence imaging for bacterial cell biology: from localization to dynamics, from ensembles to single molecules. Annu Rev Microbiol 68: 459–476. doi: 10.1146/annurev-micro-091213-113034 [DOI] [PubMed] [Google Scholar]
  • 23.Armentrout EI, Rietsch A (2016) The Type III Secretion Translocation Pore Senses Host Cell Contact. PLoS Pathog 12: e1005530. doi: 10.1371/journal.ppat.1005530 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gawthorne JA, Audry L, McQuitty C, Dean P, Christie JM, Enninga J, et al. (2016) Visualizing the Translocation and Localization of Bacterial Type III Effector Proteins by Using a Genetically Encoded Reporter System. Appl Environ Microbiol 82: 2700–2708. doi: 10.1128/AEM.03418-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Goser V, Kommnick C, Liss V, Hensel M (2019) Self-Labeling Enzyme Tags for Analyses of Translocation of Type III Secretion System Effector Proteins. mBio 10. doi: 10.1128/mBio.00769-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Van Engelenburg SB, Palmer AE (2010) Imaging type-III secretion reveals dynamics and spatial segregation of Salmonella effectors. Nat Methods 7: 325–330. doi: 10.1038/nmeth.1437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Enninga J, Mounier J, Sansonetti P, Tran Van Nhieu G (2005) Secretion of type III effectors into host cells in real time. Nat Methods 2: 959–965. doi: 10.1038/nmeth804 [DOI] [PubMed] [Google Scholar]
  • 28.Ehsani S, Rodrigues CD, Enninga J (2009) Turning on the spotlight—using light to monitor and characterize bacterial effector secretion and translocation. Curr Opin Microbiol 12: 24–30. doi: 10.1016/j.mib.2008.11.007 [DOI] [PubMed] [Google Scholar]
  • 29.Gotzke H, Kilisch M, Martinez-Carranza M, Sograte-Idrissi S, Rajavel A, Schlichthaerle T, et al. (2019) The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications. Nat Commun 10: 4403. doi: 10.1038/s41467-019-12301-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Charpentier X, Oswald E (2004) Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. J Bacteriol 186: 5486–5495. doi: 10.1128/JB.186.16.5486-5495.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Wolters M, Boyle EC, Lardong K, Trulzsch K, Steffen A, Rottner K, et al. (2013) Cytotoxic necrotizing factor-Y boosts Yersinia effector translocation by activating Rac protein. J Biol Chem 288: 23543–23553. doi: 10.1074/jbc.M112.448662 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wolters M, Zobiak B, Nauth T, Aepfelbacher M (2015) Analysis of Yersinia enterocolitica Effector Translocation into Host Cells Using Beta-lactamase Effector Fusions. J Vis Exp. doi: 10.3791/53115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Sarantis H, Balkin DM, De Camilli P, Isberg RR, Brumell JH, Grinstein S (2012) Yersinia entry into host cells requires Rab5-dependent dephosphorylation of PI(4,5)P(2) and membrane scission. Cell Host Microbe 11: 117–128. doi: 10.1016/j.chom.2012.01.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bekere I, Huang J, Schnapp M, Rudolph M, Berneking L, Ruckdeschel K, et al. (2021) Yersinia remodels epigenetic histone modifications in human macrophages. PLoS Pathog 17: e1010074. doi: 10.1371/journal.ppat.1010074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Feeley EM, Pilla-Moffett DM, Zwack EE, Piro AS, Finethy R, Kolb JP, et al. (2017) Galectin-3 directs antimicrobial guanylate binding proteins to vacuoles furnished with bacterial secretion systems. Proc Natl Acad Sci U S A 114: E1698–E1706. doi: 10.1073/pnas.1615771114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Zwack EE, Feeley EM, Burton AR, Hu B, Yamamoto M, Kanneganti TD, et al. (2017) Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components. Infect Immun 85. doi: 10.1128/IAI.00778-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Paz I, Sachse M, Dupont N, Mounier J, Cederfur C, Enninga J, et al. (2010) Galectin-3, a marker for vacuole lysis by invasive pathogens. Cell Microbiol 12: 530–544. doi: 10.1111/j.1462-5822.2009.01415.x [DOI] [PubMed] [Google Scholar]
  • 38.Pilla-Moffett D, Barber MF, Taylor GA, Coers J (2016) Interferon-Inducible GTPases in Host Resistance, Inflammation and Disease. J Mol Biol 428: 3495–3513. doi: 10.1016/j.jmb.2016.04.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kutsch M, Coers J (2021) Human guanylate binding proteins: nanomachines orchestrating host defense. FEBS J 288: 5826–5849. doi: 10.1111/febs.15662 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Kutsch M, Sistemich L, Lesser CF, Goldberg MB, Herrmann C, Coers J (2020) Direct binding of polymeric GBP1 to LPS disrupts bacterial cell envelope functions. EMBO J 39: e104926. doi: 10.15252/embj.2020104926 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Santos JC, Boucher D, Schneider LK, Demarco B, Dilucca M, Shkarina K, et al. (2020) Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria. Nat Commun 11: 3276. doi: 10.1038/s41467-020-16889-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Sheahan KL, Isberg RR (2015) Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity. mBio 6: e02023–02014. doi: 10.1128/mBio.02023-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Kutsch M, Coers J (2021) Human guanylate binding proteins: nanomachines orchestrating host defense. FEBS J 288: 5826–5849. doi: 10.1111/febs.15662 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Chang YY, Stevenin V, Duchateau M, Giai Gianetto Q, Hourdel V, Rodrigues CD, et al. (2020) Shigella hijacks the exocyst to cluster macropinosomes for efficient vacuolar escape. PLoS Pathog 16: e1008822. doi: 10.1371/journal.ppat.1008822 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Carsten A, Rudolph M, Weihs T, Schmidt R, Wurm CA, Diepold A, et al. (2021) Visualization of bacterial type 3 secretion system components down to the molecular level by MINFLUX nanoscopy. bioRxiv: 2021.2009.2027.461991. [Google Scholar]
  • 46.Balla T, Varnai P (2009) Visualization of cellular phosphoinositide pools with GFP-fused protein-domains. Curr Protoc Cell Biol Chapter 24: Unit 24 24. doi: 10.1002/0471143030.cb2404s42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Aspenstrom P, Fransson A, Saras J (2004) Rho GTPases have diverse effects on the organization of the actin filament system. Biochem J 377: 327–337. doi: 10.1042/BJ20031041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Maejima I, Takahashi A, Omori H, Kimura T, Takabatake Y, Saitoh T, et al. (2013) Autophagy sequesters damaged lysosomes to control lysosomal biogenesis and kidney injury. EMBO J 32: 2336–2347. doi: 10.1038/emboj.2013.171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Koberle M, Klein-Gunther A, Schutz M, Fritz M, Berchtold S, Tolosa E, et al. (2009) Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model. PLoS Pathog 5: e1000551. doi: 10.1371/journal.ppat.1000551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Riedl J, Crevenna AH, Kessenbrock K, Yu JH, Neukirchen D, Bista M, et al. (2008) Lifeact: a versatile marker to visualize F-actin. Nat Methods 5: 605–607. doi: 10.1038/nmeth.1220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Oellerich MF, Jacobi CA, Freund S, Niedung K, Bach A, Heesemann J, et al. (2007) Yersinia enterocolitica infection of mice reveals clonal invasion and abscess formation. Infect Immun 75: 3802–3811. doi: 10.1128/IAI.00419-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Yan MY, Yan HQ, Ren GX, Zhao JP, Guo XP, Sun YC (2017) CRISPR-Cas12a-Assisted Recombineering in Bacteria. Appl Environ Microbiol 83: e00947–17. doi: 10.1128/AEM.00947-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Heesemann J, Laufs R (1983) Construction of a mobilizable Yersinia enterocolitica virulence plasmid. J Bacteriol 155: 761–767. doi: 10.1128/jb.155.2.761-767.1983 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Trulzsch K, Roggenkamp A, Aepfelbacher M, Wilharm G, Ruckdeschel K, Heesemann J (2003) Analysis of chaperone-dependent Yop secretion/translocation and effector function using a mini-virulence plasmid of Yersinia enterocolitica. Int J Med Microbiol 293: 167–177. doi: 10.1078/1438-4221-00251 [DOI] [PubMed] [Google Scholar]
  • 55.Kopp P, Lammers R, Aepfelbacher M, Woehlke G, Rudel T, Machuy N, et al. (2006) The kinesin KIF1C and microtubule plus ends regulate podosome dynamics in macrophages. Mol Biol Cell 17: 2811–2823. doi: 10.1091/mbc.e05-11-1010 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Raphael H Valdivia, Jorn Coers

14 Feb 2022

Dear Dr. Wolters,

Thank you very much for submitting your manuscript "Live imaging of Yersinia translocon formation and immune recognition in host cells" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

The manuscript implements a novel methodology to study the dynamics of the Yersinia T3SS translocon complex. Reviewers were unanimously enthusiastic about the study. However, all 3 reviewers raised several concerns regarding technical aspects of the paper that will need to be resolved for a revised MS to be accepted. Especially noteworthy concerns raised by the reviewers center around the questions of whether ALFA tagging/ binding of the nanobody could block translocon function, whether NbALFA loss of signal is definitively reflecting loss of YopD, and why bacteria are found intracellularly in spite of their anti-phagocytic effectors. The study also implicated a role for GBPs and/or galectin-3 in YopD degradation. While these were potentially exciting preliminary findings, the reviewers criticized that the paper didn't provide direct evidence for such a model, e.g. by using cells deficient for GBPs/ Galectin-3. Exploring the biology of YopD 'degradation' further and especially probing for the functional roles of GBPs/ galectins in this process - while certainly desirable - may be beyond the scope of this study and therefore in lieu of more data, the authors could also decide to taper down the biology aspect of their paper, and revise the paper carefully to avoid making unsupported claims.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Jorn Coers

Pearls Editor

PLOS Pathogens

Raphael Valdivia

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

The manuscript implements a novel methodology to study the dynamics of the Yersinia T3SS translocon complex. Reviewers were unanimously enthusiastic about the study. However, all 3 reviewers also raised several concerns regarding technical aspects of the paper that will need to be resolved for a revised MS to be accepted. Especially noteworthy concerns raised by the reviewers center around the questions of whether ALFA tagging/ binding of the nanobody could block translocon function, whether NbALFA loss of signal is definitively reflecting loss of YopD, and why bacteria are found intracellularly in spite of their anti-phagocytic effectors. The study also implicated a role for GBPs and/or galectin-3 in YopD degradation. While these were potentially exciting preliminary findings, the reviewers criticized that the paper didn't provide direct evidence for such a model, e.g. by using cells deficient for GBPs/ Galectin-3. Exploring the biology of YopD 'degradation' further and especially probing for the functional roles of GBPs/ galectins in this process - while certainly desirable - may be beyond the scope of this study and therefore in lieu of more data, the authors could also decide to taper down the biology aspect of their paper, and revise the paper carefully to avoid making unsupported claims.

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: The manuscript “Live imaging of Yersinia translocon formation and immune recognition in host cells” establishes a new technique using fluorescent nanobodies that recognize an ALFA tag to image the dynamics of translocon complex formation and “degradation” in situ using time lapse fluorescence imaging. The translocon complex is a major constituent of the type 3 secretion system, a molecular device acting as a molecular syringe used by many gram-negative bacterial pathogens. It is crucial for the delivery of bacterial effector proteins into the host cell. Despite its importance the translocon complex cannot easily studied, most likely due to its transient insertion into host cell membranes, and limitations working with its purified components in vitro. Therefore, the approach developed in this manuscript is welcome and has the potential to provide not only important insights into Yersinia cell invasion, however it could also be developed for other bacteria. Overall, the manuscript is written very clearly, and the presented data is well described. Together, it’s a great piece that will be very relevant for infection biologists working on secretion machines, such as the T3SS. Nevertheless, there are some overinterpretations in the text (the authors provide often only correlative data, which does not allow causal interpretations)- these issues can easily be amended down-toning some of the biological interpretations. Furthermore, the manuscript could be strengthened by some additional controls that the authors may already have, but not included in the piece, or that could be executed in a reasonable amount of time. I feel that a revised manuscript would become a very strong paper for PLoS Pathogens. Below, I state the points that should be addressed by the authors:

Reviewer #2: This manuscript takes a novel and creative approach to studying the mechanisms of Yersinia type III secretion in cells, by tagging a key translocon protein, YopD, with an ALFA tag that can be detected with nano-bodies. using this tag, the authors find that the translocon is formed in a pre-phagosomal compartment, which is not entirely surprising given that Yersinia is an extracellular pathogens and transolcates effectors from the outside of the cell. The authors furthermore use the ALFA-tagged YopD to follow the fate of translocons over time, and find that galectin-3 and GBP-1 are recruited to the phhagosome, followed by loss of the signal, suggesting degradation of the translocon. This is an intriguing approach to studying hte dynamics of translocation with a protein that is essential for the functioning of the translocon, and will likey be applicable to many other such approaches. That being said, I have some questions about the general applicability of these findings to Yersinia biology, given that the function of the Yops is to prevent phagocytosis, and that Yersinia replicates extracellularly.

Reviewer #3: In the manuscript “Live imaging of Yersinia translocon formation and immune recognition in host cells,” Rudolph et al. use live imaging studies leveraging an ALFA-tag-binding nanobodies to track the timing and localization of Yersinia enterocolitica’s YopD as a proxy for translocon formation. They demonstrate that YopD is integrated into translocons just minutes after interaction with host cells. They go on to show that YopD is associated with phosphatidylinositol-4.5-bisphosphate enriched membranes early during infection. At later timepoints they report that YopD signal colocalizes with galectin-3 and guanylate-binding protein-1 (GBP-1), which coincides with a decrease in YopD signal. The authors suggest that this might be due to degradation of the translocon via galectin-3 and/or GBP-1 mediated pathway.

The questions tackled by these authors is important: understanding the kinetics and location of translocon formation will provide insights into Yersinia virulence mechanisms. Their live imaging approach is particularly exciting, as it may be adaptable to the study of other bacterial pathogens that encode TTSSs/translocons. Their report that translocon colocalization with Gal-3 and GBP1 coincides with loss of YopD signal, is an intriguing finding. That said, there are several important caveats that should be addressed to fully support the conclusions drawn in this manuscript.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: I would suggest experimental data on the two points below:

-Figure 1 provides convincing controls to prove that insertion of the ALFA tag does not perturb the translocon activity. However, the rest of the paper focuses on imaging of the translocon insertion, requiring the binding of a nanobody (NbALFA) to the ALFA tag. Therefore, the authors should add some data that the binding of the nanobody does not entirely block translocon function. This could be included in Figure 1.E with an experiment in the presence of the NbALFA. Similar comments could be made for Figure 1.F.

- Figure 3 onwards (important to be addressed carefully): The present study relies on observation/quantification of gain and loss of signals through the nanobody binding to the ALFA tag. The authors state that using different intervals of imaging with similar results of their data indicate limited or no photobleaching. This cannot be interpreted as such, as photobleaching relies on different parameters, for example the intensity of the incoming light (instead of the sequence). As this is such an important issue in the manuscript, additional controls should be performed. For example, this could be done by co-straining in an indirect immunofluorescence experiment with NbALFA and an anti YopD antibody at early and again at late infection times after the end of their time-lapse. Failure to detect an antibody signal at later infection stages will provide additional evidence that the NbALFA loss of signal is not due to photobleaching but really to YopD disappearance.

Reviewer #2: 1. Injection of Yops E and H blocks phagocytosis. If the translocon is functioning appropriately, how is Yersinia entering the cell? I recognize that some portion of Yersinia are indeed inside the cell, but these would presumably be bacteria whose T3SS was not functioning as well. It is important to know how the conclusions here impact the extracellular bacteria that are presumably the pool of replicating ones.

2. The authors conclude from the loss of YopD fluorescence signal that it is being degraded. Is it fair to conclude that? Could recruitment of galectin and GBPs to the phagosome and bacterial membrane interfere with the ability of the nanobody to bind to YopD? Is there a way to measure the levels of YopD by western blotting of digitonin-treated cells which should provide access to the extracellular YopD pool?

3. Can the authors perform these studies in the absence of Gbps (GbgpChr3-/- cells for example?) a prediction of their model is that the translocon should not be degraded in these cells.

4. Given that YopD itself is translocated, how do the authors know that the YopD they are imaging is part of a functional translocon, rather than YopD that is being translocated into the cytosol of the target cell? This seems important to address to be able to support the conclusion being reached. If the translocon is degraded in a GBP-dependent manner, presumably in the absence of GBPs, that degradation would not occur, and there should be more translocated effectors, which could be measured by beta-lactamase assay.

Reviewer #3: Overall the manuscript is written well, however there is important details that are lacking throughout the manuscript that make the experimental design/data/figures hard to understand. For example: there was limited information about the strain background. Was the tagged YopD complementing a deltaYopD mutant or was there an endogenous copy? I also had to dig for the MOIs, conditions for the secretion assay, beta-lactamase reporter, etc. More detail in the results section is absolutely required to enhance the manuscript.

The major advance of this manuscript is the ability to potentially visualize the formation, localization and overall dynamics of the translocon. Since this is a new technique that the entire manuscript hinges on, there needs to be additional evidence to indicate that the authors are indeed visualizing the translocon. One way this could be addressed is via biochemical isolation of phagosomal membranes, followed by western blot analysis probing for YopD at key time points. This type of experiment would support their conclusion that they are indeed visualizing YopD/the translocon (enrichment of the protein in the membrane fraction should coincide with visualization of ALFA-tag-binding nanobodies in their time-lapse movies). In addition, further modulating of the system would help support the conclusion that they are the visualizing YopD/the translocon. For example, the authors state that cells expressing myc-Rac1Q61L strongly increases translocon expression. Does expression of myc-Rac1Q61L (compared to controls) increase YopD signal in the live imaging system?

The authors find YopD signal colocalizes with galectin-3 and guanylate-binding (GBP-1), which coincides with a decrease in YopD signal. The authors suggest that this might be due to degradation of the translocon via galectin-3 and/or GBP-1 mediated pathway. This is potentially very interesting and the dependency is testable. It would greatly enhance their findings if the authors can conclude that YopD half-life is impacted by galectin-3 and GBP-1. Using gal-3 and GBP-1 knockdowns or knockouts and visualizing the spaciotemporal localization of YopD via live cell imaging/western blot would help draw such conclusions. In addition, modulating the system (e.g. inhibiting vacuole acidification or macrophage activation) and measuring how YopD signal changes over time would give additional support. This set of experiments will help give deeper insights into the relationship of Gal-3 and GBP-1 to YopD. Without this data this is simply an observation that the Yersinia translocon colocalizes with markers of membrane damage.

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: -Figure 2.B – The STED data is very good and relates very well to previous work of the authors using translocon specific antibodies. I am wondering how to interpret the dot in the middle of the bacterium, as it appears that this translocon is not fully in focus. Therefore, the authors should include a 3D STED dataset or they should use a dataset where the translocons out of focus do not complicate the interpretation of the data.

-Figure 3. The authors state that T3SS translocon pore is inserted after PIP2 enrichment of the vacuolar membrane. I am wondering whether this recruitment does already require some T3SS effector injection. As PIP2 is normally strongly enriched at the plasma membrane (it is well depicted on Figure 3C), and then it gets depleted during phagosome formation, one wonders when does the T3SS really start to deliver effectors… the authors should discuss possible limitations of the fluorescence signals and also relate this to previous work from the Grinstein lab.

Figure 4G: The GBP signal does not label all phagosomes/vacuoles that contain bacteria- this is interesting and the authors may want to discuss this issue.

Movie relating to 4G and figure: at later time points, there are unspecific signals of the nanobody channel- what are these signals? They are not translocons that are carried away to some other compartments (for example for degradation?)? Please discuss this issue.

The authors use the myc-Rac1Q61L cell line which provides a boost in translocon insertion and the observed infection dynamics. It has been used by the authors before, and it would be good to explain this again in this work, so that the reader can follow why it was used.

Important general comment: The paper tends to over-interpret some observations without providing additional experiments needed to prove such statements. Of course, it would be possible to address this with extra experiments, however, as the work appears as a proof-of-concept method work, one could down-tone the writing, and suggest experiments to really proof “causal” relationships in the future. A number of examples for this are

*Lines 166-169: It is not clear whether PIP2 insertion is required for translocon insertion from the shown experiments. The data is a simple correlation. Here, experiments with inhibitors or kinases and phosphatases would be required to really mark the point. Nevertheless, this could simply be discussed.

Similar issues

*Lines 192-193: here again, two fluorescence signals are correlated, but a causal link is beyond the acquired data. This can easily be discussed.

*Lines 207-209: the shielding of GBP to avoid antibody binding is speculative and would require more controls- again, this could be suggested and elaborated in the discussion.

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Decision Letter 1

Raphael H Valdivia, Jorn Coers

21 Apr 2022

Dear Dr. Wolters,

We are pleased to inform you that your manuscript 'Live imaging of Yersinia translocon formation and immune recognition in host cells' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Jörn Coers

Pearls Editor

PLOS Pathogens

Raphael Valdivia

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

The authors put in place a convincing method to study the dynamics of the insertion of the bacterial type 3 secretion system translocon into the plasma membrane of infected cells. The paper constitutes an important technical advance for the field and the reviews were overwhelmingly positive. The minor technical concerns raised by the reviewers were convincingly addressed in the revisions

Reviewer Comments (if any, and for reference):

Acceptance letter

Raphael H Valdivia, Jorn Coers

18 May 2022

Dear Prof. Aepfelbacher,

We are delighted to inform you that your manuscript, "Live imaging of Yersinia translocon formation and immune recognition in host cells," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. NbALFA does not inhibit WA-314 YopD-ALFA effector translocation or cytotoxicity.

    (A) Digitonin assay. Hela cells were infected with WA-314 YopD-ALFA at an MOI of 100. NbALFA-580 was diluted in cell culture medium as indicated. Cells were lyzed with digitonin and resulting supernatants (containing membrane integrated and soluble Yops from host cells) and cell pellets (containing intact bacteria and digitonin insoluble cell components) were analyzed with Western blot for the indicated proteins. YopH serves as marker for effector translocation, myc indicates myc-Rac1QL61 expression, calnexin serves as host cell loading control and HSP60 serves as bacterial loading and lysis control. Data are representative of 2 independent experiments. (B) Cytotoxicity assay. HeLa cells were infected for 1 h with WA-314 YopD-ALFA at an MOI of 100 and imaged by phase contrast microscopy. NbALFA was diluted in cell culture medium as indicated. Depicted are phase contrast images of a representative experiment. Scale bar: 20 μm.

    (TIF)

    S2 Fig. Rac1Q61L expression enhances translocon formation by WA-314 YopD-ALFA in Hela cells.

    Control or myc-Rac1Q61L transfected Hela cells were infected with WA-314 YopD-ALFA at an MOI of 50 for 50 min, fixed and stained with NbALFA-647 (shown in red) with prior permeabilization of host cell membranes using digitonin. Cells are visualized using phalloidin 488 (shown in green). Scale bar: 20 μm.

    (TIF)

    S3 Fig. Live imaging of fixed and stained YopD-ALFA.

    Hela cells were infected at an MOI of 50 for 50 minutes, fixed, permeabilized with digitonin and incubated with NbALFA-580 and phalloidin 488. After addition of cell culture medium, cells were imaged with a spinning disk microscope recording z-stacks every minute for 105 min employing the same imaging conditions as for live cell imaging (e.g. for Fig 4E). The z-stacks for each time point were combined to one image using maximum intensity projection and one image every 15 min is representatively shown. The left panel shows the overview image at 0 min. The boxed region in the overview image shows the area of the video depicted in still frames to the right. Scale bars: 20 μm (overview) and 5 μm (still frames). The relative fluorescence intensity of the NbALFA-580 signals were plotted. For comparison, the live cell imaging data from Fig 4E were included in the graph.

    (TIF)

    S4 Fig. Low translocon associated YopD-ALFA/YopD fluorescence signals in GFP-galectin-3 positive compartments.

    (A) NbALFA staining of translocon associated YopD-ALFA in fixed cells. HeLa cells expressing myc-Rac1Q61L and GFP-galectin-3 were infected with WA-314-YopD-ALFA at an MOI of 50 for 50 min. Cells were fixed, permeabilized with digitonin and stained with NbALFA-647. Scale bars: Overview 10 μm, zoom 2 μm. (B) Semiquantitative categorization of NbALFA signal intensities in galectin-3 positive and negative compartments. Experimental conditions as in A. Bacteria in galectin-3 negative and positive compartments were categorized according to the intensity of YopD-ALFA signals (+/-: no/weak intensity; ++: medium intensity; +++: strong intensity). Total number of bacteria evaluated: n = 400 (C) Immunostaining of translocon associated YopD in fixed cells. Experimental conditions as in A but infection with WA-314 and staining with purified polyclonal anti-YopD antibody. Scale bars: Overview 10 μm, zoom 2 μm.

    (TIF)

    S1 Movie. Live imaging of translocons during HeLa cell infection.

    HeLa cells expressing myc-Rac1Q61L and GFP-LifeAct were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in the cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every minute. Stacks for each time point were combined to one image using maximum intensity projection. Scale bar: 2 μm.

    (AVI)

    S2 Movie. Engulfment in PIP2-positive membranes precedes translocon formation in HeLa cells.

    HeLa cells expressing myc-Rac1Q61L and PLCδ1-PH-GFP were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every 20 s. Stacks for each time point were combined to one image using maximum intensity projection. Scale bar: 2 μm.

    (AVI)

    S3 Movie. Engulfment in PIP2-positive membranes precedes translocon formation in primary human macrophages.

    Primary human macrophages expressing PLCδ1-PH-GFP were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every minute. Stacks for each time point were combined to one image using maximum intensity projection. Scale bar: 2 μm.

    (AVI)

    S4 Movie. Galectin-3 recruitment to vacuoles containing translocon forming bacteria.

    HeLa cells expressing myc-Rac1Q61L and GFP-galectin-3 were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every minute. The z-stacks for each time point were combined to one image using maximum intensity projection. Scale bar: 2 μm.

    (AVI)

    S5 Movie. GBP-1 recruitment to galectin-3 positive bacteria.

    HeLa cells expressing myc-Rac1Q61L, mScarlet-galectin-3 (shown in green) and GFP-GBP-1 (shown in red) were infected with WA-314 YopD-ALFA at an MOI of 20 and incubated with NbALFA-580 (shown in magenta) diluted in cell culture medium. Cells were imaged with a spinning disk microscope recording z-stacks every 5 minutes. The z-stacks for each time point were combined to one image using maximum intensity projection. Scale bar: 5 μm.

    (AVI)

    Attachment

    Submitted filename: Response to reviewers.pdf

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Pathogens are provided here courtesy of PLOS

    RESOURCES